Galapagos, Gilead

Galapagos, after research struggles, will split in two and revamp Gilead deal
Alongside plans to spin out a new company, the Belgian drugmaker said it will cut some 300 positions, or about 40% of its current workforce.
Galapagos to split itself into two companies as part of turnaround plan
The beleaguered Belgian firm Galapagos is splitting itself into two companies, with the brandname biotech prioritizing oncology.
Galapagos to amend Gilead deal; to spin off innovative medicines unit
Belgian biotech Galapagos (NASDAQ:GLPG) announced a major restructuring drive on Wednesday, with plans to amend its 10-year collaboration with Gilead (NASDAQ:GILD) as part of its intention to create a new publicly traded entity focused on innovative medicines.
Galapagos to split itself into two companies, lay off 40% of staff
Galapagos will gain full development and commercialization rights to its pipeline, and is subject to single digit royalty payments to Gilead on the sales of certain products.
Galapagos to Spin Out Innovative Medicines, Regain Gilead Assets
By mid-2025, the biotech will split into two entities: a new, as-yet-unnamed innovative medicines specialist and a cell therapy company, the latter of which will inherit the Galapagos name.
Galapagos to amend Gilead deal amid spinoff plans
Galapagos (GLPG) stock is in focus as the company looks to amend its 10-year deal with Gilead (GILD) as part of plans to create a new listed unit. Read more here.
FierceBiotech2d
Galapagos splits in 2, laying off 40% of staff, shrinking pipeline and ending Gilead partnership
After the separation, Gilead will hold around 25% of the outstanding shares in both Galapagos and the spin-off company. While ...
Stocktwits on MSN2d
Galapagos Stock Surges On Strategic Spin-Off And Restructuring Plans: Retail Turns Extremely Bullish
U.S.-listed shares rose over 4% in Wednesday's premarket after it announced a significant restructuring plan, including a ...
Biotech Firm Galapagos to Split Into Two Entities, Cut Jobs
Belgian biotech company Galapagos NV plans to spin off part of its operations, creating a new listed firm with approximately ...
Barclays Keeps Their Hold Rating on Galapagos (0JXZ)
In a report released today, Emily Field from Barclays maintained a Hold rating on Galapagos (0JXZ – Research Report), with a price target of ...
Galapagos Unveils 2025 Split To Accelerate Innovation, Sharpen Strategic Focus
Galapagos NV plans to split into two entities by mid-2025, focusing on oncology cell therapy and innovative medicines, with ...
FierceBiotech22h
Fierce Biotech Layoff Tracker 2025: IGM Biosciences reduces workforce by 73%; Galapagos lays off 300 staffers
We hoped industry layoffs would relent in 2024. That's not what happened. | As always, if you know of layoffs occurring at a ...
Galapagos Strategic Restructuring Raises Concerns Despite Potential Value Unlock
Leerink Partners analyst Faisal Khurshid has maintained their neutral stance on GLPG stock, giving a Hold rating on December 23.Stay Ahead of ...
These Surprising New G-SHOCK Watches Help Protect the Galápagos
During his famed voyage on the HMS Beagle, Charles Darwin noted about the Galápagos Islands that “by far the most remarkable ...